|
[1]
|
Davidson, K.W., Alcántara, C. and Miller, G.E. (2018) Selected Psychological Comorbidities in Coronary Heart Disease: Challenges and Grand Opportunities. American Psychologist, 73, 1019-1030. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Hemingway, H. and Marmot, M. (1999) Evidence Based Cardiology: Psychosocial Factors in the Aetiology and Prognosis of Coronary Heart Disease: Systematic Review of Prospective Co-hort Studies. BMJ, 318, 1460-1467. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
王征宇. 症状自评量(SCL-90) [J]. 上海精神医学, 1984(2): 68-70.
|
|
[4]
|
Rampidis, G.P., Benetos, G., Benz, D.C., Giannopoulos, A.A. and Buechel, R.R. (2019) A Guide for Gensini Score Calculation. Atherosclerosis, 287, 181-183. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Gensini, G.G. (1983) A More Meaningful Scoring Sys-tem for Determining the Severity of Coronary Heart Disease. The American Journal of Cardiology, 51, 606. [Google Scholar] [CrossRef]
|
|
[6]
|
Malakar, A.K., Choudhury, D., Halder, B., Paul, P., Uddin, A. and Chakraborty, S. (2019) A Review on Coronary Artery Disease, Its Risk Factors, and Therapeutics. Journal of Cellular Physiology, 234, 16812-16823. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Ösby, U., Correia, N., Brandt, L., Ekbomb, A. and Sparén, P. (2000) Time Trends in Schizophrenia Mortality in Stockholm County, Sweden: Cohort Study. BMJ, 321, 483-484. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Kasteng, F., Eriksson, J., Sennfält, K. and Lindgren, P. (2011) Metabolic Effects and Cost-Effectiveness of Aripiprazole versus Olanzapine in Schizophrenia and Bipolar Disorder. Acta Psychiatrica Scandinavica, 124, 214-225. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
郭纪群, 葛均波. 血尿酸与冠状动脉粥样硬化程度的关系[J]. 中国心血管杂志, 2013, 18(5): 346-349.
|
|
[10]
|
Lichtman, J.H., Froelicher, E.S., Blumenthal, J.A., et al. (2014) Depression as a Risk Factor for Poor Prognosis among Patients with Acute Coronary Syndrome: Systematic Review and Recommendations: A Scientific Statement from the American Heart Association. Circulation, 129, 1350-1369. [Google Scholar] [CrossRef]
|
|
[11]
|
Kleber, M.E., Delgado, G., Grammer, T.B., et al. (2015) Uric Acid and Cardiovascular Events: A Mendelian Randomization Study. Journal of the American Society of Nephrology, 26, 2831-2838. [Google Scholar] [CrossRef]
|
|
[12]
|
Lim, D.-H., Lee, Y., Park, G.-M., et al. (2019) Serum Uric Acid Level and Subclinical Coronary Atherosclerosis in Asymptomatic Individuals: An Observational Cohort Study. Athero-sclerosis, 288, 112-117. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Kunutsor, S.K., Apekey, T.A. and Khan, H. (2014) Liver Enzymes and Risk of Cardiovascular Disease in the General Population: A Meta-Analysis of Prospective Cohort Studies. Atherosclerosis, 236, 7-17. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Kaplan, M.M. (1972) Alkaline Phosphatase. New Eng-land Journal of Medicine, 286, 200-202. [Google Scholar] [CrossRef]
|
|
[15]
|
Matsubara, Y., Kiyohara, H., Teratani, T., Mikami, Y. and Kanai, T. (2022) Organ and Brain Crosstalk: The Liver-Brain Axis in Gastrointestinal, Liver, and Pancreatic Diseases. Neuropharmacology, 205, Article ID: 108915. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Ballaz, S.J. and Bourin, M. (2021) Cholecystokin-in-Mediated Neuromodulation of Anxiety and Schizophrenia: A “Dimmer-Switch” Hypothesis. Current Neuropharma-cology, 19, 925-938. [Google Scholar] [CrossRef]
|
|
[17]
|
张萌萌, 徐又佳, 侯建明, 等. 骨质疏松实验室诊断及影响因素专家共识2022 [J]. 中国骨质疏松杂志, 2022, 28(9): 1249-1259.
|
|
[18]
|
Huang, T.-L. and Lin, C.-C. (2015) Advances in Biomarkers of Major Depressive Disorder. In: Makowski, G.S., Ed., Advances in Clinical Chemis-try, Vol. 68, Academic Press, Cambridge, 177-204. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Ndrepepa, G., Xhepa, E., Braun, S., et al. (2017) Alkaline Phos-phatase and Prognosis in Patients with Coronary Artery Disease. European Journal of Clinical Investigation, 47, 378-387. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Sforzini, L., Pariante, C.M., Palacios, J.E., et al. (2019) Inflamma-tion Associated with Coronary Heart Disease Predicts Onset of Depression in a Three-Year Prospective Follow-up: A Preliminary Study. Brain, Behavior, and Immunity, 81, 659-664. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Kim, J.-M., Stewart, R., Kim, J.-W., et al. (2019) Modifying Effects of Depression on the Association between BDNF Methylation and Rognosis of Acute Coronary Syndrome. Brain, Be-havior, and Immunity, 81, 422-429. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Deter, H.C., Orth-Gomér, K., Rauch-Kröhnert, U., et al. (2021) De-pression, Anxiety, and Vital Exhaustion Are Associated with Pro-Coagulant Markers in Depressed Patients with Coro-nary Artery Disease—A Cross Sectional and Prospective Secondary Analysis of the SPIRR-CAD Trial. Journal of Psy-chosomatic Research, 151, Article ID: 110659. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Amare, A., Schubert, K., Klingler-Hoffmann, M., Co-hen-Woods, S. and Baune, B.T. (2017) The Genetic Overlap Between Mood Disorders and Cardiometabolic Diseases: A Systematic Review of Genome Wide and Candidate Gene Studies. Translational Psychiatry, 7, e1007. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Kang, H.-J., Stewart, R., Kim, J.-W., et al. (2020) Synergistic Effects of Depression and NR3C1 Methylation on Prognosis of Acute Coronary Syndrome. Scientific Reports, 10, Article No. 5519. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Kloner, R.A. (2019) The Brain-Heart Connection and the Northridge Earthquake. Cardiology in Review, 27, 171-172. [Google Scholar] [CrossRef]
|